Galderma Announces Intention to Expand Manufacturing and Innovation Footprint in Asia-Pacific

2022年10月15日 13:44:31 来自: (0)参与

Galderma, the pure-play dermatology category leader, announces its intention to explore opportunities to build its fifth manufacturing plant in Singapore
Supported by the Singapore Economic Development Board, the new facility is expected to increase Galderma’s manufacturing capacity by up to 350 million units per year, in response to continuing demand for premium science-based products in the Dermo-cosmetics sector

ZUG, Switzerland--(BUSINESS WIRE)--Reaffirming its bold ambition to become the leading dermatology company in the world, Galderma today announced its intention to expand its manufacturing and innovation footprint in the Asia-Pacific region, with support from the Singapore Economic Development Board. Galderma intends to explore opportunities to build a fifth manufacturing plant with a high degree of digitalization and automation in Singapore in response to growing consumer demand and to support long-term sustainable growth over the coming years.

The announcement comes as part of Galderma’s strategic manufacturing roadmap, aligned with the company’s unique Integrated Dermatology Strategy. Following a record 2021 performance, Galderma has demonstrated strong commercial and financial performance in the first half of 2022, with continued strong growth across product categories. In particular, Dermo-cosmetics has grown by 31% year-on-year on a constant currency basis, fueled by the strong performance of Cetaphil® driven by e-commerce and launches in China and the rest of Asia.

“Our goal is to support our strong growth trajectory in the long-term with a new manufacturing plant that will significantly increase our capacity to serve consumers with premium brands from our differentiated Dermo-cosmetics portfolio across geographies, and primarily throughout our key markets in Asia-Pacific. We sincerely thank the Economic Development Board of Singapore for its support, and we look forward to further collaboration to bring this exciting project to life.”

FLEMMING ØRNSKOV, M.D., MPH
CHIEF EXECUTIVE OFFICER
GALDERMA

 
相关新闻
本网网友:m/m  撕心裂肺°
评论:梦想是用来破灭的,不是用来实现的,因为在现实面前,它就是一个屁。

天涯网友:我瘋癫我快樂
评论:世界上没有绝对幸福圆满的婚姻,幸福只是来自于无限的容忍与互相尊重。

天猫网友:别走停下来
评论:有一天,全世界都不要你了。不要慌,来找我,我会告诉你,我也不要你。

网易网友:我會很愛你
评论:把你的样子当成黑白照,裱个相框供在心里,想你了,就烧几柱香。

淘宝网友:△丑角  3/5,°
评论:小时候认为流血了就是很严重的事,不管疼不疼,先哭了再说.

搜狐网友:肆虐ヽ Ragingヽ
评论:我说过我爱你。没说我只爱你。

其它网友:強悍的是命運
评论:领“鲜”一步

腾讯网友:memory’青春
评论:今天情人节出去玩,卖花的小姑娘拉着我:“大哥哥,买花吧,一看就知道你是花心的人”……

百度网友:时光安好moon
评论:食堂一直是个大问题 最近越来越怀疑那些食堂的人究竟是炊事员还是饲养员 ...

凤凰网友:心悲 2/2star°
评论:我是一个很有原则的人,我的原则只有三个字,看心情

新闻转自网络媒体,如有侵权,请与我们联系:1160322105@qq.com责编:admin